| Wendi Medved, PHARMD | |
|
780 Simms St Ste 103, Golden, CO 80401-4725 | |
| (303) 237-4478 | |
| Not Available |
| Full Name | Wendi Medved |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 780 Simms St Ste 103, Golden, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841914678 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 18535 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wendi Medved, PHARMD 780 Simms St Ste 103, Golden, CO 80401-4725 Ph: (303) 237-4478 | Wendi Medved, PHARMD 780 Simms St Ste 103, Golden, CO 80401-4725 Ph: (303) 237-4478 |
News Archive
Boehringer Ingelheim's investigational tyrosine kinase inhibitor (TKI) BIBF 1120 demonstrated a positive trend in reducing lung function decline in patients with idiopathic pulmonary fibrosis (IPF), according to phase II clinical trial results published today online in the New England Journal of Medicine.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
Separating infants and their mothers after a Caesarean section delivery is common. A new study published in Acta Paediatrica has found that providing skin-to-skin contact with the father may provide benefits to a newborn.
The National Community Pharmacists Association (NCPA) commended the Senate for passing a bill extending from Sept. 30 to Dec. 31, 2009 the deadline for meeting pharmacy accreditation requirements to continue offering Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., a pharmaceutical company strongly committed to the respiratory, primary care and CNS therapeutic areas, presented results from SETTLE Phase III study with safinamide at the 17th International Congress of Parkinson's disease and Movement Disorders, taking place from June 16 to 20, 2013, at the Sydney Convention and Exhibition Centre, Sydney, Australia.
› Verified 6 days ago
Ashley Toombs, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1707 Cole Blvd Ste 100, Golden, CO 80401 Phone: 720-530-3440 | |
Brian T Le, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17171 S Golden Rd, Golden, CO 80401 Phone: 303-279-5684 Fax: 303-279-5898 | |
James Aldridge, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1286 Wyoming St, Golden, CO 80403 Phone: 303-720-1021 | |
Gregory John Sabatos, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 607 Somerset Dr, Golden, CO 80401 Phone: 720-840-4466 | |
Dr. Sarah Carman Rivas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 780 Simms St Ste 103, Golden, CO 80401 Phone: 303-237-4478 Fax: 303-237-4478 | |
Dr. Theresa Cao, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15000 W 6th Ave, Golden, CO 80401 Phone: 303-495-8543 | |
Rachel Haggard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 231 Violet St, Golden, CO 80401 Phone: 800-525-9473 |